IL6 and congenital rubella syndrome: Emerging evidence implicates IL6 as a central mediator of toxicity in cytokine release syndrome (CRS) [62]; therefore, these findings suggest that a rapid and severe deterioration during SARS-CoV-2 infection into COVID-19 is associated with CRS/cytokine storm syndrome [63,64].